Investigate Efficacy, Safety, and Pharmacokinetics of Enzastaurin for the Prevention of Arterial Events in Patients With Enzastaurin in Vascular Ehlers-Danlos Syndrome.

Condition:   Vascular Ehlers-Danlos Syndrome Interventions:   Drug: Enzastaurin;   Drug: Placebo Sponsors:   Aytu BioPharma, Inc.;   Parexel Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials